drug discovery natural products: end era endless frontier 
historically majority new drugs generated natural products secondary metabolites compounds derived natural products past years pharmaceutical industry research natural products declined part emphasis high-throughput screening synthetic libraries currently substantial decline new drug approvals impending loss patent protection important medicines however untapped biological resources smart screening methods robotic separation structural analysis metabolic engineering synthetic biology offer exciting technologies new natural product drug discovery advances rapid genetic sequencing coupled manipulation biosynthetic pathways may provide vast resource future discovery pharmaceutical agents 
